Medicare (Traditional Part A & B) · epidural steroid injection
✓ conditional · medicare lcd
Criteria checklist
0 of 8 ticked- enumerated: yes
- covered:
- name: Radiculopathy, radicular pain and/or neurogenic claudication
- criteria:
- etiology: disc herniation, osteophyte(s)/osteophyte complexes, or severe degenerative disc disease producing foraminal or central spinal stenosis
- evidence: history + physical exam + CONCORDANT radiological image-based diagnostic testing (WPS/CGS text names imaging only — no electrodiagnostic route)
- severity: severe enough to greatly impact quality of life or function; objective pain or functional scale at baseline, repeated at each follow-up (same scale)
- min duration: >=4 weeks of pain AND (documented failure of >=4 weeks of noninvasive conservative care OR inability to tolerate it)
- imaging guided: CT or fluoroscopy with contrast (see exception in imaging_guidance)
- name: Post-laminectomy syndrome
- criteria:
- evidence: history + physical exam + concordant radiological image-based diagnostic testing
- severity: greatly impacts quality of life or function; baseline + follow-up scale required
- min duration: >=4 weeks of pain AND (failed >=4 weeks noninvasive conservative care OR unable to tolerate)
- name: Acute herpes zoster-associated pain refractory to conservative management
- criteria:
- wait exception: the 4-week wait is NOT required
- investigational:
- non-specific low back pain, axial spine pain, CRPS, widespread diffuse pain, neuropathy from other causes, cervicogenic headache
- ultrasound guidance or no image guidance — EXCEPT documented contrast allergy or pregnancy, where ultrasound without contrast may be considered
- repeat injection without documented >=50% improvement (pain or ADL/function, same scale) for >=3 months from the prior ESI (exception: failed initial ESI may be repeated after >=14 days with a different approach/level/medication, rationale documented)
- exceeding 4 sessions per spinal region per rolling 12 months; more than 1 spinal region per session
- TFESI at >2 nerve-root levels per session; CESI/ILESI at >1 level per session; bilateral CESI/ILESI
- a predetermined series of ESIs
- biologicals or substances not FDA-designated for epidural use
- multiple blocks (sympathetic, facet, trigger point) in the same session as ESI — except facet-synovial-cyst + ESI
- continuation beyond 12 months without the documented continuation criteria (see quantity_limits)
- required: yes
- min duration months: not stated in the policy
- satisfied by:
- tried and failed >=4 weeks
- unable to tolerate
- acute herpes zoster refractory to conservative management (no 4-week wait)
- modalities named:
- NSAIDs / analgesics
- physical therapy
- spinal manipulation
- activity modification / other
- note: ESIs should be performed in conjunction with conservative treatment; patient should be in an active rehab / home-exercise / functional-restoration program
- required: no
- min duration days: not stated in the policy
- success criteria: not stated in the policy
- threshold is binding: no
- required: no
- must clear: no
- note posture: not required
- required: yes
- modalities:
- fluoroscopy
- CT
- contrast: required — initial contrast injection confirms epidural placement
- excluded:
- ultrasound
- no-imaging / landmark-only
- exception: documented contrast allergy or pregnancy: ultrasound guidance without contrast may be considered
- applies: yes
- repeat requires: >=50% improvement (pain or ADL/function, same scale as baseline) for >=3 months from the prior injection
- failed initial repeat: if the initial ESI fails, one repeat after >=14 days with a different approach/level/medication, with documented rationale
- sessions per region per 12mo: 4
- regions per session: 1
- tfesi max levels per session: 2
- cesi ilesi max levels per session: 1
- beyond 12 months: requires severe functional/vocational disability + >=50% sustained improvement (pain and/or function) + documented rationale (high-risk surgical candidate / declines surgery / recurrence after >=3-month relief) + PCP notified; may trigger focused medical review
- no predetermined series: yes
Governed by the harmonized multi-MAC "Epidural Steroid Injections for Pain Management" LCD — WPS L39054 (IN), CGS L39015 (KY). ESI is for RADICULAR-pattern pathology (radiculopathy / radicular pain / neurogenic claudication, post-laminectomy syndrome, acute herpes zoster pain) — the mirror image of the facet LCD (axial pain). Key gates: >=4 weeks of pain AND failure of (or inability to tolerate) >=4 weeks of noninvasive conservative care (herpes zoster exempt from the wait); CONCORDANT radiological imaging supporting the diagnosis; CT/fluoro guidance WITH CONTRAST (ultrasound only for documented contrast allergy or pregnancy); TFESI <=2 levels, CESI/ILESI 1 level, one region per session; repeat only after >=50% improvement x >=3 months (or one 14-day different-approach retry after a failed initial); <=4 sessions/region/rolling 12 months; continuation past 12 months needs the documented continuation criteria. Sedation (moderate/deep, MAC, GA) is rarely indicated and not reasonable-and-necessary absent case-specific documentation — oral anxiolytics typically suffice. Contraindicated with spinal/systemic infection, cord/conus/cauda compressive lesions, or major cancer risk factors. Criteria VERIFIED 2026-07-24 against both LCD bodies read directly from the MCD (browser pull); WPS/CGS texts materially identical. The IN/KY billing articles are A58777 (WPS) / A58731 (CGS).
Ticks are a documentation aid — nothing is stored; they reset on reload.
Dot phrase
Lean narrative A&P attestation. `***` = fill-in. Maps to WPS L39054 (IN) / CGS L39015 (KY) "Epidural Steroid Injections" LCD (bodies verified 2026-07-24). This is the RADICULAR mirror of the facet phrase — name the nerve root and the concordant imaging.
.ESIMCARE Assessment: *** — [radiculopathy / radicular pain / neurogenic claudication due to *** (disc herniation, osteophyte complex, severe DDD with foraminal/central stenosis) | post-laminectomy syndrome | acute herpes zoster-associated pain] in a *** (C/T/L-S) distribution, severe enough to greatly impact function and quality of life (baseline pain/functional scale ***), with concordant radiological imaging at *** correlating with the symptomatic level. Medical necessity per the Medicare LCD (Epidural Steroid Injections for Pain Management): pain has been present >=4 weeks, and >=4 weeks of noninvasive conservative care — NSAIDs/analgesics, physical therapy, spinal manipulation, and activity modification — has failed or was not tolerated: *** . [Herpes zoster: refractory to conservative management; no 4-week wait required.] The patient is participating in an active rehabilitation, home-exercise, or functional-restoration program. There is no contraindication: no spinal or systemic infection, no cord/conus/cauda compression, and no major cancer risk. The injection will be placed under fluoroscopy or CT with contrast, the initial contrast confirming epidural placement. [Contrast allergy or pregnancy documented: ultrasound without contrast.] Plan: *** epidural steroid injection — transforaminal (64483/64484 lumbar-sacral; 64479/64480 cervical-thoracic; <=2 levels, bilateral only if clinically indicated) or interlaminar/caudal (62323 lumbar-sacral; 62321 cervical-thoracic; 1 level, unilateral) — to a single spinal region this session under fluoroscopic/CT guidance with contrast. [If repeat:] the prior ESI gave >=50% improvement in pain or function on the same scale for >=3 months [or: the initial ESI failed and I am repeating after >=14 days via a different approach/level/medication because ***]. Risks, benefits, and alternatives discussed; consent obtained.
Where this payor diverges from the Medicare baseline
Cautions
Prior-auth pathway
- required: no
- verified: no
- note: Not on a verified OPD prior-auth category for ESI codes; confirm if furnished hospital-outpatient.
Provenance
- authority:
- type: lcd
- title: Epidural Steroid Injections for Pain Management
- lcds:
- IN: L39054 (WPS, J8) — v17 eff 2026-04-30 (body verified via MCD browser pull 2026-07-24)
- KY: L39015 (CGS, J15) — v16 eff 2026-04-16 (body verified via MCD browser pull 2026-07-24; WPS/CGS texts materially identical)
- applies because: WPS (IN) and CGS (KY) each publish this LCD; criteria are the harmonized multi-MAC standard
- billing articles:
- A58777 (WPS, IN)
- A58731 (CGS, KY)
- source: https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?lcdid=39054&ver=17
- effective: 2026-04-30 · payor last reviewed: 2026-04-30 · we verified: 2026-07-24 · v2
Change history
- 2026-07-24esi/medicare v2: LCD bodies verified via MCD browser pull (first direct read); WPS L39054 v17 + CGS L39015 v16 materially identical; cell trued-up (post-laminectomy + herpes-zoster indications, contrast-allergy/pregnancy ultrasound exception, level/region caps, 14-day failed-initial repeat, >12-month continuation gate, sedation limits); removed unsupported electrodiagnostics evidence route; needs_reverification cleared; dot phrase regenerated
64eaa6ee59 - 2026-07-23Medicare LCD cells: correct billing-article MAC attributions (verified via CMS MCP)
33eb0065ae - 2026-06-28Add Epidural Steroid Injections x Medicare IN/KY cell (LCD)
90328c2d5b